VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $516,000 | -23.3% | 32,408 | +0.0% | 0.01% | -30.0% |
Q4 2017 | $673,000 | -90.1% | 32,406 | -93.2% | 0.01% | -90.0% |
Q3 2017 | $6,807,000 | -52.2% | 475,002 | -42.3% | 0.10% | -50.0% |
Q2 2017 | $14,239,000 | +3486.6% | 823,046 | +5355.0% | 0.20% | +4900.0% |
Q1 2016 | $397,000 | -97.5% | 15,088 | -83.0% | 0.00% | -97.4% |
Q3 2015 | $15,818,000 | +16.4% | 88,677 | +44.9% | 0.15% | +35.1% |
Q2 2015 | $13,591,000 | +4.4% | 61,178 | -6.6% | 0.11% | +15.2% |
Q1 2015 | $13,016,000 | -69.2% | 65,531 | -77.8% | 0.10% | -71.1% |
Q4 2014 | $42,308,000 | +5338.0% | 295,632 | +4689.9% | 0.34% | +3320.0% |
Q2 2014 | $778,000 | – | 6,172 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |